Orphan Medicinal Products and patient Advocacy Group

Orphan drugs are medicinal products that are used to treat rare diseases. They are called “orphan drugs” because due to their limited in market, only few pharmaceutical companies pursue research into such products. These drugs would not be produce without government assistance.

List of orphan medicinal products in Europe with European orphan designation

 

  • Adcetris
  • Adempas
  • Hetlioz
  • ChenodeoxycHolicAcidLeadiant
  • Besponsa
  • Iclusig
  • Ketoconazlehra
  • Namuscla
  • Roxon

Related Conference of Orphan Medicinal Products and patient Advocacy Group

September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany
September 13-14, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
October 21-22, 2021

International Conference on Tropical Diseases and Cure

Zurich, Switzerland
November 22-23, 2021

3rd World Congress on Advancements in Tuberculosis and Lung Diseases

Singapore City, Singapore
February 07-08, 2022

9th International Congress on Infectious Diseases

Aberdeen, UK

Orphan Medicinal Products and patient Advocacy Group Conference Speakers

Recommended Sessions

Related Journals

Are you interested in